Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Patrys Limited ( (AU:PAB) ) has shared an update.
Patrys Limited has announced a change in the holdings of its directors following the consolidation of the company’s issued capital on a fifteen-for-one basis. This consolidation, approved by shareholders, reflects a strategic move to streamline the company’s capital structure, potentially impacting its market positioning and shareholder value.
More about Patrys Limited
Based in Melbourne, Australia, Patrys Limited is a therapeutic antibody development company focused on its deoxymab platform of cell-penetrating antibodies for various indications.
Average Trading Volume: 1,151,168
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$8.86M
For an in-depth examination of PAB stock, go to TipRanks’ Overview page.